Prudential plc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
4,112
+2,065
| +101% | +$673K | 0.01% | 458 |
|
|
2025
Q1 | $553K | Sell |
2,047
-2,233
| -52% | -$603K | ﹤0.01% | 573 |
|
|
2024
Q4 | $1.01M | Buy |
4,280
+1,264
| +42% | +$297K | 0.01% | 510 |
|
|
2024
Q3 | $829K | Buy |
3,016
+143
| +5% | +$39.3K | ﹤0.01% | 549 |
|
|
2024
Q2 | $698K | Hold |
2,873
| – | – | ﹤0.01% | 539 |
|
|
2024
Q1 | $429K | Sell |
2,873
-1,994
| -41% | -$298K | ﹤0.01% | 621 |
|
|
2023
Q4 | $932K | Sell |
4,867
-11
| -0.2% | -$2.11K | 0.01% | 601 |
|
|
2023
Q3 | $864K | Sell |
4,878
-761
| -13% | -$135K | 0.01% | 570 |
|
|
2023
Q2 | $1.07M | Sell |
5,639
-81
| -1% | -$15.4K | 0.01% | 552 |
|
|
2023
Q1 | $1.15M | Buy |
5,720
+6
| +0.1% | +$1.2K | 0.01% | 513 |
|
|
2022
Q4 | $1.36M | Buy |
5,714
+3,617
| +172% | +$860K | 0.02% | 462 |
|
|
2022
Q3 | $420K | Buy |
2,097
+316
| +18% | +$63.3K | 0.01% | 628 |
|
|
2022
Q2 | $260K | Hold |
1,781
| – | – | ﹤0.01% | 734 |
|
|
2022
Q1 | $291K | Buy |
+1,781
| New | +$291K | ﹤0.01% | 736 |
|